Ilkka Lappalainen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ilkka Lappalainen has a total of 292 co-authors. Here are the top co-authors by number of shared publications:
- Mauno Vihinen
Affiliation Department of Experimental Medical Science, Lund University, Lund, Sweden
9 shared publications - Paul Flicek
European Molecular Biology Laboratory, European Bioinformatics Institute
7 shared publications - John Dylan Spalding
European Bioinformatics Institute, European Molecular Biology Laboratory, Wellcome Genome Campus, Hinxton, Cambridge, UK
4 shared publications Jordi Rambla
Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
4 shared publications- Mikael Linden
CSC - IT Center for Science Ltd, Espoo, Finland
4 shared publications - Serena Scollen
ELIXIR Hub, Wellcome Genome Campus, Hinxton, Cambridge, UK
4 shared publications
Latest Publications
- 13 September 2019
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 20 (11) , 702
Author Correction: Leveraging European infrastructures to access 1 million human genomes by 2022
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 13 September 2019
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 20 (11) , 702
Author Correction: Leveraging European infrastructures to access 1 million human genomes by 2022
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 27 August 2019
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 20 (11) , 693-701
Leveraging European infrastructures to access 1 million human genomes by 2022
Human genomics is undergoing a step change from being a predominantly research-driven activity to one driven through health care as many countries in Europe now have nascent precision medicine programmes. To maximize the value of the genomic data generated, these data will need to be shared between institutions and across countries. In recognition of this challenge, 21 European countries recently signed a declaration to transnationally share data on at least 1 million human genomes by 2022. In this Roadmap, we identify the challenges of data sharing across borders and demonstrate that European research infrastructures are well-positioned to support the rapid implementation of widespread genomic data access.
- 27 August 2019
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 20 (11) , 693-701
Leveraging European infrastructures to access 1 million human genomes by 2022
Human genomics is undergoing a step change from being a predominantly research-driven activity to one driven through health care as many countries in Europe now have nascent precision medicine programmes. To maximize the value of the genomic data generated, these data will need to be shared between institutions and across countries. In recognition of this challenge, 21 European countries recently signed a declaration to transnationally share data on at least 1 million human genomes by 2022. In this Roadmap, we identify the challenges of data sharing across borders and demonstrate that European research infrastructures are well-positioned to support the rapid implementation of widespread genomic data access.
- Open Access
- 4 March 2019
- Published by Springer Nature in Nature Biotechnology
- Vol. 37 (3) , 220-224
Federated discovery and sharing of genomic data using Beacons
- 4 March 2019
- Published by Springer Nature in Nature Biotechnology
- Vol. 37 (3) , 220-224
Open AccessFederated discovery and sharing of genomic data using Beacons
- Open Access
- 6 August 2018
- Published by F1000 Research Ltd in F1000Research
- Vol. 7, 1199
Common ELIXIR Service for Researcher Authentication and Authorisation
A common Authentication and Authorisation Infrastructure (AAI) that would allow single sign-on to services has been identified as a key enabler for European bioinformatics. ELIXIR AAI is an ELIXIR service portfolio for authenticating researchers to ELIXIR services and assisting these services on user privileges during research usage. It relieves the scientific service providers from managing the user identities and authorisation themselves, enables the researcher to have a single set of credentials to all ELIXIR services and supports meeting the requirements imposed by the data protection laws. ELIXIR AAI was launched in late 2016 and is part of the ELIXIR Compute platform portfolio. By the end of 2017 the number of users reached 1000, while the number of relying scientific services was 36. This paper presents the requirements and design of the ELIXIR AAI and the policies related to its use, and how it can be used for serving some example services, such as document management, social media, data discovery, human data access, cloud compute and training services.
- 6 August 2018
- Published by F1000 Research Ltd in F1000Research
- Vol. 7, 1199
Open AccessCommon ELIXIR Service for Researcher Authentication and Authorisation
A common Authentication and Authorisation Infrastructure (AAI) that would allow single sign-on to services has been identified as a key enabler for European bioinformatics. ELIXIR AAI is an ELIXIR service portfolio for authenticating researchers to ELIXIR services and assisting these services on user privileges during research usage. It relieves the scientific service providers from managing the user identities and authorisation themselves, enables the researcher to have a single set of credentials to all ELIXIR services and supports meeting the requirements imposed by the data protection laws. ELIXIR AAI was launched in late 2016 and is part of the ELIXIR Compute platform portfolio. By the end of 2017 the number of users reached 1000, while the number of relying scientific services was 36. This paper presents the requirements and design of the ELIXIR AAI and the policies related to its use, and how it can be used for serving some example services, such as document management, social media, data discovery, human data access, cloud compute and training services.
- Open Access
- 2 August 2018
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 26 (12) , 1721-1731
Registered access: authorizing data access
The Global Alliance for Genomics and Health (GA4GH) proposes a data access policy model—“registered access”—to increase and improve access to data requiring an agreement to basic terms and conditions, such as the use of DNA sequence and health data in research. A registered access policy would enable a range of categories of users to gain access, starting with researchers and clinical care professionals. It would also facilitate general use and reuse of data but within the bounds of consent restrictions and other ethical obligations. In piloting registered access with the Scientific Demonstration data sharing projects of GA4GH, we provide additional ethics, policy and technical guidance to facilitate the implementation of this access model in an international setting.
- 2 August 2018
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 26 (12) , 1721-1731
Open AccessRegistered access: authorizing data access
The Global Alliance for Genomics and Health (GA4GH) proposes a data access policy model—“registered access”—to increase and improve access to data requiring an agreement to basic terms and conditions, such as the use of DNA sequence and health data in research. A registered access policy would enable a range of categories of users to gain access, starting with researchers and clinical care professionals. It would also facilitate general use and reuse of data but within the bounds of consent restrictions and other ethical obligations. In piloting registered access with the Scientific Demonstration data sharing projects of GA4GH, we provide additional ethics, policy and technical guidance to facilitate the implementation of this access model in an international setting.
- Open Access
- 19 June 2018
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (1) , 119-121
htsget: a protocol for securely streaming genomic data
Standardized interfaces for efficiently accessing high-throughput sequencing data are a fundamental requirement for large-scale genomic data sharing. We have developed htsget, a protocol for secure, efficient and reliable access to sequencing read and variation data. We demonstrate four independent client and server implementations, and the results of a comprehensive interoperability demonstration. http://samtools.github.io/hts-specs/htsget.html Supplementary data are available at Bioinformatics online.
- 19 June 2018
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (1) , 119-121
Open Accesshtsget: a protocol for securely streaming genomic data
Standardized interfaces for efficiently accessing high-throughput sequencing data are a fundamental requirement for large-scale genomic data sharing. We have developed htsget, a protocol for secure, efficient and reliable access to sequencing read and variation data. We demonstrate four independent client and server implementations, and the results of a comprehensive interoperability demonstration. http://samtools.github.io/hts-specs/htsget.html Supplementary data are available at Bioinformatics online.
- Open Access
- 4 April 2017
- Published by F1000 Research Ltd
- Vol. 6
ELIXIR Beacon
The ELIXIR Beacon project – part of the current ELIXIR Implementation Study on Human Data defines the Beacon query interface, user authentication and authorization mechanisms and the service security requirements together with the Global Alliance for Genomics and Health (GA4GH). The project also aims to understand the national cohort and biobank requirements for sharing their data using the Beacon service. EMBL‐EBI, Belgium, Finland, France, Netherlands, Spain, Sweden and Switzerland are partners.
- 4 April 2017
- Published by F1000 Research Ltd
- Vol. 6
Open AccessELIXIR Beacon
The ELIXIR Beacon project – part of the current ELIXIR Implementation Study on Human Data defines the Beacon query interface, user authentication and authorization mechanisms and the service security requirements together with the Global Alliance for Genomics and Health (GA4GH). The project also aims to understand the national cohort and biobank requirements for sharing their data using the Beacon service. EMBL‐EBI, Belgium, Finland, France, Netherlands, Spain, Sweden and Switzerland are partners.
- Open Access
- 23 March 2017
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 17 (1) , 30
Orchestrating differential data access for translational research: a pilot implementation
Translational researchers need robust IT solutions to access a range of data types, varying from public data sets to pseudonymised patient information with restricted access, provided on a case by case basis. The reason for this complication is that managing access policies to sensitive human data must consider issues of data confidentiality, identifiability, extent of consent, and data usage agreements. All these ethical, social and legal aspects must be incorporated into a differential management of restricted access to sensitive data. In this paper we present a pilot system that uses several common open source software components in a novel combination to coordinate access to heterogeneous biomedical data repositories containing open data (open access) as well as sensitive data (restricted access) in the domain of biobanking and biosample research. Our approach is based on a digital identity federation and software to manage resource access entitlements. Open source software components were assembled and configured in such a way that they allow for different ways of restricted access according to the protection needs of the data. We have tested the resulting pilot infrastructure and assessed its performance, feasibility and reproducibility. Common open source software components are sufficient to allow for the creation of a secure system for differential access to sensitive data. The implementation of this system is exemplary for researchers facing similar requirements for restricted access data. Here we report experience and lessons learnt of our pilot implementation, which may be useful for similar use cases. Furthermore, we discuss possible extensions for more complex scenarios.
- 23 March 2017
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 17 (1) , 30
Open AccessOrchestrating differential data access for translational research: a pilot implementation
Translational researchers need robust IT solutions to access a range of data types, varying from public data sets to pseudonymised patient information with restricted access, provided on a case by case basis. The reason for this complication is that managing access policies to sensitive human data must consider issues of data confidentiality, identifiability, extent of consent, and data usage agreements. All these ethical, social and legal aspects must be incorporated into a differential management of restricted access to sensitive data. In this paper we present a pilot system that uses several common open source software components in a novel combination to coordinate access to heterogeneous biomedical data repositories containing open data (open access) as well as sensitive data (restricted access) in the domain of biobanking and biosample research. Our approach is based on a digital identity federation and software to manage resource access entitlements. Open source software components were assembled and configured in such a way that they allow for different ways of restricted access according to the protection needs of the data. We have tested the resulting pilot infrastructure and assessed its performance, feasibility and reproducibility. Common open source software components are sufficient to allow for the creation of a secure system for differential access to sensitive data. The implementation of this system is exemplary for researchers facing similar requirements for restricted access data. Here we report experience and lessons learnt of our pilot implementation, which may be useful for similar use cases. Furthermore, we discuss possible extensions for more complex scenarios.
- Open Access
- 26 June 2015
- Published by Springer Nature in Nature Genetics
- Vol. 47 (7) , 692-695
The European Genome-phenome Archive of human data consented for biomedical research
Paul Flicek and colleagues provide an update on the European Genome-phenome Archive (EGA), a service of the European Bioinformatics Institute (EMBL-EBI) and the Center for Genome Regulation (CRG). The authors describe the EGA policies and infrastructure, how access decisions are made, methods for data submission and future plans for expansion of this database. The European Genome-phenome Archive (EGA) is a permanent archive that promotes the distribution and sharing of genetic and phenotypic data consented for specific approved uses but not fully open, public distribution. The EGA follows strict protocols for information management, data storage, security and dissemination. Authorized access to the data is managed in partnership with the data-providing organizations. The EGA includes major reference data collections for human genetics research.
- 26 June 2015
- Published by Springer Nature in Nature Genetics
- Vol. 47 (7) , 692-695
Open AccessThe European Genome-phenome Archive of human data consented for biomedical research
Paul Flicek and colleagues provide an update on the European Genome-phenome Archive (EGA), a service of the European Bioinformatics Institute (EMBL-EBI) and the Center for Genome Regulation (CRG). The authors describe the EGA policies and infrastructure, how access decisions are made, methods for data submission and future plans for expansion of this database. The European Genome-phenome Archive (EGA) is a permanent archive that promotes the distribution and sharing of genetic and phenotypic data consented for specific approved uses but not fully open, public distribution. The EGA follows strict protocols for information management, data storage, security and dissemination. Authorized access to the data is managed in partnership with the data-providing organizations. The EGA includes major reference data collections for human genetics research.
- Open Access
- 26 November 2012
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 41 (D1) , D936-D941
dbVar and DGVa: public archives for genomic structural variation
Much has changed in the last two years at DGVa (http://www.ebi.ac.uk/dgva) and dbVar (http://www.ncbi.nlm.nih.gov/dbvar). We are now processing direct submissions rather than only curating data from the literature and our joint study catalog includes data from over 100 studies in 11 organisms. Studies from human dominate with data from control and case populations, tumor samples as well as three large curated studies derived from multiple sources. During the processing of these data, we have made improvements to our data model, submission process and data representation. Additionally, we have made significant improvements in providing access to these data via web and FTP interfaces.
- 26 November 2012
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 41 (D1) , D936-D941
Open AccessdbVar and DGVa: public archives for genomic structural variation
Much has changed in the last two years at DGVa (http://www.ebi.ac.uk/dgva) and dbVar (http://www.ncbi.nlm.nih.gov/dbvar). We are now processing direct submissions rather than only curating data from the literature and our joint study catalog includes data from over 100 studies in 11 organisms. Studies from human dominate with data from control and case populations, tumor samples as well as three large curated studies derived from multiple sources. During the processing of these data, we have made improvements to our data model, submission process and data representation. Additionally, we have made significant improvements in providing access to these data via web and FTP interfaces.